The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-[1-(10H-9-Thia-1,4,10-triaza-anthracen-6-ylmethyl)-piperidin-4-yl]-acetamide ID: ALA4170909
PubChem CID: 11100349
Max Phase: Preclinical
Molecular Formula: C18H21N5OS
Molecular Weight: 355.47
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC(=O)NC1CCN(Cc2ccc3c(c2)Nc2nccnc2S3)CC1
Standard InChI: InChI=1S/C18H21N5OS/c1-12(24)21-14-4-8-23(9-5-14)11-13-2-3-16-15(10-13)22-17-18(25-16)20-7-6-19-17/h2-3,6-7,10,14H,4-5,8-9,11H2,1H3,(H,19,22)(H,21,24)
Standard InChI Key: CSRHPCOGCXTMMQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
18.8889 -16.8391 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8878 -17.6586 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5958 -18.0676 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5940 -16.4302 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3026 -16.8355 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3015 -17.6561 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0077 -18.0651 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
21.0100 -16.4239 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.7160 -16.8308 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7190 -17.6545 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4327 -18.0619 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.1439 -17.6468 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.1369 -16.8200 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4226 -16.4163 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.1811 -16.4306 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4735 -16.8394 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.7677 -16.4262 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0622 -16.8315 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0582 -17.6490 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7659 -18.0596 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4775 -17.6527 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3491 -18.0551 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.3462 -18.8723 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6370 -19.2784 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0524 -19.2834 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
5 8 1 0
6 7 1 0
7 10 1 0
9 8 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 9 1 0
1 15 1 0
15 16 1 0
16 17 1 0
16 21 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
19 22 1 0
22 23 1 0
23 24 1 0
23 25 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 355.47Molecular Weight (Monoisotopic): 355.1467AlogP: 2.79#Rotatable Bonds: 3Polar Surface Area: 70.15Molecular Species: NEUTRALHBA: 6HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.84CX Basic pKa: 7.71CX LogP: 1.35CX LogD: 0.87Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.75Np Likeness Score: -1.30
References 1. Pluta K, Jeleń M, Morak-Młodawska B, Zimecki M, Artym J, Kocięba M, Zaczyńska E.. (2017) Azaphenothiazines - promising phenothiazine derivatives. An insight into nomenclature, synthesis, structure elucidation and biological properties., 138 [PMID:28734245 ] [10.1016/j.ejmech.2017.07.009 ]